Navigation Links
Codexis to Present at the Jefferies and Pacific Crest Conferences
Date:2/8/2011

REDWOOD CITY, Calif., Feb. 8, 2011 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS) today announced the company will present at the Jefferies Global Clean Technology Conference, to be held in New York, NY on February 23-24, 2011. The presentation is scheduled for February 23 at 1:00 p.m. Eastern Time.  

The company will also present at the Pacific Crest Clean Technology Conference, to be held in San Francisco, CA on March 1-2, 2011. The presentation is scheduled for March 1 at 1:30 p.m. Pacific Time.  

Both presentations will be made by Robert Lawson, Senior Vice President and Chief Financial Officer.  An audio webcast and replay for both conferences will be available in the Investor section of www.codexis.com.  

Codexis is a clean technology company. Codexis develops optimized biocatalysts that make industrial processes faster, cleaner and more efficient. Codexis' technology is commercialized with leading global pharmaceutical companies and in development for advanced biofuels with Shell and carbon capture with Alstom. Other potential markets for the company's biocatalyst-enabled solutions include chemicals and water treatment.
For more information, see www.codexis.comContacts:  Media:  Lyn Christenson, lyn.christenson@codexis.com, 650-421-8144 or Saskia Sidenfaden, ssidenfaden@mww.com,

212-827-3771.Investors:  Robert Lawson, robert.lawson@codexis.com, 650-421-8137
'/>"/>

SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Codexis Signs First Japanese Biocatalysis Collaboration With Dainippon Sumitomo Pharma
2. Codexis to Announce Fourth Quarter 2010 Financial Results on February 3, 2011
3. Codexis to Present at Piper Conference
4. Codexis to Announce Third Quarter 2010 Financial Results October 28, 2010
5. Codexis Expands Codex® Panel Product Family at CPhI
6. Codexis to Present at the Pacific Crest Technology Leadership Forum
7. Codexis Names Peter Strumph SVP, Commercial Operations
8. Codexis CEO Alan Shaw Named Ernst & Young Entrepreneur Of The Year® 2010 Recipient in Northern California
9. Codexis, Inc. Announces Pricing of Initial Public Offering
10. Codexis Expands Pharmaceutical Manufacturing Partnerships
11. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work ... in environments where the rule of law has been degraded. The PSC.1 standard ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
Breaking Medicine News(10 mins):